结核疫苗和治疗药物:挑战和未来的方向
Yajing An1,2, Ruizi Ni2, Li Zhuang2
1Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The Eighth Medical Center of PLA General Hospital, 17#Heishanhu Road, Haidian District, Beijing, 100091, China.
Molecular biomedicine
|January 22, 2025
概括
由于抗药性增加,迫切需要新的结核病 (TB) 疫苗和治疗方法. 本综述探讨了目前的结核病疫苗开发,贝达基林等新型治疗剂,以及改善预防和治疗策略的未来研究方向.
科学领域:
- 传染性疾病 传染性疾病
- 疫苗学 疫苗学 疫苗学
- 药理学 药理学是指药理学的学科.
背景情况:
- 结核病 (TB) 每年造成超过100万人的死亡,抗药性菌株的增加需要改进干预措施.
- 目前的疫苗和治疗方法面临着局限性,这凸显了对*Mycobacterium tuberculosis*的新方法的迫切需要.
研究的目的:
- 审查结核病疫苗开发的现状,重点关注抗原发现,临床试验和像mRNA这样的创新平台.
- 检查当代结核病治疗方法,包括多药耐药结核病 (MDR-TB) 和宿主导治疗的药物.
- 确定结核病疫苗和治疗研究的挑战和未来方向.
主要方法:
- 关于当代结核病疫苗和治疗开发的综合文献综述.
- 对结核病疫苗抗原鉴定策略和临床试验进展的分析.
- 对结核病新兴治疗剂和新型平台技术的评估.
主要成果:
- 创新的结核病疫苗方法包括多抗原策略和mRNA技术.
- 有前途的MDR-TB疗法包括贝达基林 (BDQ) 和德拉曼尼德 (DLM).
- 关键的挑战包括抗原多样性,不同人群中的疫苗有效性和诊断局限性.
结论:
- 推进结核病预防和治疗需要克服疫苗和药物开发中的重大障碍.
- 未来的战略包括组合方法,新药标和个性化医疗.
- 本综述提供了洞察力,以指导未来的研究,以获得有效的结核病疫苗和治疗方法.
相关概念视频
Pulmonary Tuberculosis V
170
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
170
Pulmonary Tuberculosis IV
132
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
132
Pulmonary Tuberculosis II
211
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
211
Pulmonary Tuberculosis I
220
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
220
Cancer Vaccines
332
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
332
Pulmonary Tuberculosis III
301
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
301


